MedTrace Logo

Factors Associated With Acceptance of Home-Based Pulmonary Telerehabilitation in COPD

NCT07747571 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-08-10

No results posted yet for this study

Summary

Pulmonary rehabilitation improves symptoms, exercise capacity, and quality of life in people with chronic obstructive pulmonary disease (COPD), but access and participation may be limited by travel, organizational, logistical, and personal barriers. Home-based pulmonary telerehabilitation may reduce some of these barriers, although not all eligible individuals accept this mode of care. Identifying the characteristics associated with acceptance or refusal of this model is therefore essential to better define the population most likely to benefit from this approach, tailor the program's delivery and content, and identify potential remaining barriers in order to improve access to care.

This retrospective study will use existing data from adults with COPD who were screened at ADIR Association between May 2024 and April 2025 for an 8-week home-based pulmonary telerehabilitation feasibility study. Of 50 potentially eligible individuals, 21 accepted participation and 29 declined. Demographic, clinical, functional, psychological, and geographic characteristics will be compared between individuals who accepted and those who declined participation. Documented reasons for refusal will be described, and factors associated with refusal will be explored using logistic regression.

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Pulmonary Rehabilitation

Interventions

OTHER

No intervention

None for the present retrospective study.

Sponsors & Collaborators

  • University of Rouen Normandie

    collaborator OTHER

  • Hopital La Musse

    collaborator OTHER

  • ADIR Association

    lead OTHER

Principal Investigators

  • Tristan Bonnevie, PhD · ADIR Association

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2026-10-31
Completion
2026-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07747571 on ClinicalTrials.gov